Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 TreatmentAmy Q. Wang, Xin Xu, Wenwei Huang et al.|Frontiers in Pharmacology|2022Cited by 31
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs <i>in vitro</i>Qi Zhang, Yihong Ye, Catherine Z. Chen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 13
Preclinical Pharmacokinetics and <i>In Vitro</i> Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 TreatmentAmy Q. Wang, Xin Xu, Wei Zheng et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2